Repository corticotropin injection (Purified Cortrophin Gel)

Purified corticotropin gel is not recommended for approval/coverage due to insufficient updated efficacy data and potential long‑term safety concerns, effectively excluding its use despite listed FDA‑approved indications (rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, edematous, nervous system). Requests can only be considered for FDA‑approved indications with documentation of the diagnosis and that the request meets the specific coverage guidelines, but evidence does not show benefit over available therapies.

"Allergic states"

Sign up to see full coverage criteria, indications, and limitations.